Work

Unraveling therapeutic targets in acute myeloid leukemia through multiplexed genome editing CRISPR screening

Year: 2023

Type: editorial

Abstract: 1. Acute myeloid leukemia (AML) is a heterogeneous disease characterized by genetic alterations and molecular abnormalities that drive the aberrant proliferation and differentiation of myeloid cell...

Source: Expert Opinion on Therapeutic Targets

DOI: 10.1080/14728222.2023.2293751

Authors: Zhen Tian, Stacia Octaviani, Jian Huang

Institutions: Coriell Institute For Medical Research, Cooper Medical School of Rowan University, Temple University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML, G1503066541, G3528453451

OpenAlex ID: W4389506866

Cites: 15

Cited by: 4

Related to: 10